盐酸右雷佐生

盐酸右雷佐生（CAS 149003-01-0）的公开数据库记录，列此仅供独立核对。

这个物质在各数据库里的编号

数据库记载的用途

• For reducing the incidence and severity of cardiomyopathy associated with doxorubicin administration in women with metastatic breast cancer who have received a cumulative doxorubicin hydrochloride dose of 300 mg/m^2 and would benefit from continued doxorubicin therapy. Also approved for the treatment of extravasation from intravenous anthracyclines.
• Breast Feeding; Lactation; Antineoplastic Agents; Cardioprotectants; Cardiotonic Agents; Enzyme Inhibitors; Topoisomerase II Inhibitors
• Dexrazoxane hydrochloride is approved to treat severe side effects caused by certain types of chemotherapy. It is used to treat the following:
• • Cardiac (heart) side effects caused by doxorubicin hydrochloride in women being treated for metastaticbreast cancer. Dexrazoxane hydrochloride helps make the side effects happen less often and makes them less severe when they do occur. It is used only in women who have already received high doses of doxorubicin and continue to be treated with it. This use is approved for the Totect and Zinecard brands of dexrazoxane hydrochloride.
• • Extravasation caused by intravenousanthracyclines. Extravasation occurs when injecteddrugs leak out of the vein, into surrounding tissue. This can cause redness, pain, and swelling, and may damage the tissue. This use is approved for the Totect brand of dexrazoxane hydrochloride.
• Substances that inhibit or prevent the proliferation of NEOPLASMS.

它在各数据库里的别名

Dexrazoxane hydrochloride; 149003-01-0; Dexrazoxane HCl; Cardioxane; Totect; Cardioxan; Savene; 1263283-43-7; ADR-529 hydrochloride; ICRF-187 hydrochloride; (+)-Razoxane hydrochloride; Razoxane hydrochloride, (S)-; 2,6-Piperazinedione, 4,4'-((1S)-1-methyl-1,2-ethanediyl)bis-, hydrochloride (1:1); 5346058Q7S; Razoxane (+)-form hydrochloride; DTXSID60164152

计算机算出的分子描述符

数据库摘要

Dexrazoxane hydrochloride · CAS 149003-01-0 · C11H17ClN4O4. UNII 5346058Q7S.

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。